J1413 Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose
Billable / valid for submission HCPCS Release 2026Q3
Short description: Inj delandistrogene mox rokl
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose | yes |
Related codes in J14
- J1410 Injection, estrogen conjugated, per 25 mg
- J1411 Injection, etranacogene dezaparvovec-drlb, per therapeutic dose
- J1412 Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes
- J1414 Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose
- J1426 Injection, casimersen, 10 mg
- J1427 Injection, viltolarsen, 10 mg
- J1428 Injection, eteplirsen, 10 mg
- J1429 Injection, golodirsen, 10 mg
- J1430 Injection, ethanolamine oleate, 100 mg
- J1434 Injection, fosaprepitant (focinvez), 1 mg
- J1435 Injection, estrone, per 1 mg
- J1436 Injection, etidronate disodium, per 300 mg
- J1437 Injection, ferric derisomaltose, 10 mg
- J1438 Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J1439 Injection, ferric carboxymaltose, 1 mg
- J1440 Fecal microbiota, live - jslm, 1 ml
- J1442 Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram
- J1447 Injection, tbo-filgrastim, 1 microgram
- J1448 Injection, trilaciclib, 1mg
- J1449 Injection, eflapegrastim-xnst, 0.1 mg